CABADAS
prevention of Coronary Artery Bypass graft occlusion by Aspirin, Dipyridamole, and Acenocoumarol/ phenprocoumon Study

Purpose
To compare the efficacy and safety of low-dose aspirin, aspirin plus dipyridamole and oral anticoagulants in the prevention of vein-graft occlusion during the first year after aortocoronary bypass surgery

References
Van der Meer J, Hillege HL, Kootstra GJ, et al: Prevention of one-year vein-graft occlusion after aortocoronary-bypass surgery: a comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulants. Lancet 1993, 342:257–264.
Mulder BJM, Van der Doef RM, Van der Wall EE,
et al: Effect of various antithrombotic regimens (aspirin, aspirin plus dipyridamole, anticoagulants) on the functional status of patients and grafts one year after coronary bypass grafting. Eur Heart J 1994, 15:1129–1134.

Voltar

Apoio: Libbs Farmacêutica Farmacêutica